- Home
- SMTK vs TTNP Comparison
SMTK vs TTNP Comparison
Compare SMTK & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTK
- TTNP
- Stock Information
- Founded
- SMTK 2009
- TTNP 1991
- Country
- SMTK United Kingdom
- TTNP United States
- Employees
- SMTK N/A
- TTNP N/A
- Industry
- SMTK
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMTK
- TTNP Health Care
- Exchange
- SMTK NYSE
- TTNP Nasdaq
- Market Cap
- SMTK 6.1M
- TTNP 5.9M
- IPO Year
- SMTK N/A
- TTNP 1996
- Fundamental
- Price
- SMTK $0.97
- TTNP $4.37
- Analyst Decision
- SMTK
- TTNP
- Analyst Count
- SMTK 0
- TTNP 0
- Target Price
- SMTK N/A
- TTNP N/A
- AVG Volume (30 Days)
- SMTK 192.5K
- TTNP 6.8K
- Earning Date
- SMTK 08-11-2025
- TTNP 08-14-2025
- Dividend Yield
- SMTK N/A
- TTNP N/A
- EPS Growth
- SMTK N/A
- TTNP N/A
- EPS
- SMTK N/A
- TTNP N/A
- Revenue
- SMTK $105,000.00
- TTNP N/A
- Revenue This Year
- SMTK N/A
- TTNP N/A
- Revenue Next Year
- SMTK N/A
- TTNP N/A
- P/E Ratio
- SMTK N/A
- TTNP N/A
- Revenue Growth
- SMTK 854.54
- TTNP N/A
- 52 Week Low
- SMTK $0.78
- TTNP $3.03
- 52 Week High
- SMTK $7.80
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SMTK N/A
- TTNP 48.42
- Support Level
- SMTK N/A
- TTNP $4.12
- Resistance Level
- SMTK N/A
- TTNP $4.65
- Average True Range (ATR)
- SMTK 0.00
- TTNP 0.19
- MACD
- SMTK 0.00
- TTNP -0.00
- Stochastic Oscillator
- SMTK 0.00
- TTNP 46.40
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.